First Dallas Securities Inc. Pfizer Inc Transaction History

First Dallas Securities Inc.

$226 Million
Q2 2024

A detailed history of First Dallas Securities Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Dallas Securities Inc. holds 25,300 shares of PFE stock, worth $750,398. This represents 0.31% of its overall portfolio holdings.

Number of Shares

25,300

Previous 20,200 25.25%

Holding current value

$750,398

Previous $561,000 26.02%

% of portfolio

0.31%

Previous 0.26%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $128,826 - $150,960	5,100 Added 25.25%	25,300 $707,000
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $138,511 - $159,055	5,350 Added 36.03%	20,200 $561,000
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $388,030 - $504,008	14,850 New	14,850 $428,000
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $531,060 - $693,240	-12,720 Reduced 57.19%	9,523 $488,000
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $715,432 - $873,363	-16,349 Reduced 42.36%	22,243 $973,000
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $524,020 - $621,324	-11,262 Reduced 22.59%	38,592 $2.02 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $5,856 - $7,256	-128 Reduced 0.26%	49,854 $2.58 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $304,239 - $450,983	7,363 Added 17.28%	49,982 $2.95 Million
Q3 2021 Oct 06, 2021	BUY	$39.25 - $50.42 $1.67 Million - $2.15 Million	42,619 New	42,619 $1.83 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $104,026 - $120,685	-3,260 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $108,427 - $115,045	3,260	3,260 $118,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Dallas Securities Inc. with notifications on news.

Account

First Dallas Securities Inc. Pfizer Inc Transaction History